CHMP1B: A Key Regulator of Chromatin Remodeling (G57132)

Target Name: CHMP1B

NCBI ID: G57132

CHMP1B

CHMP1B: A Key Regulator of Chromatin Remodeling

Chromatin-modifying proteins (CMPs) are a class of proteins that play a critical role in the regulation of gene expression and DNA replication. One of the most well-known CMPs is CHMP1B, a protein that is expressed in various tissues and is involved in the process of chromatin remodeling.

CHMP1B is a 21-kDa protein that is composed of 21 amino acid residues. It is localized to the nuclear envelope and is involved in the formation of chromatin fiber assembly. CHMP1B is one of the key components of the nucleosome, a basic unit of chromatin that consists of a core of DNA and a protein complex known as histone proteins.

CHMP1B functions as a positive regulator of the chromatin remodeling complex (RTC), a protein complex that is responsible for the remodeling of chromatin. The RTC includes several subunits, including CHMP1B, which functions as a negative regulator of the RTC.

CHMP1B plays a crucial role in the regulation of gene expression and is involved in the development, maintenance, and repair of chromatin. It is also involved in the regulation of DNA replication, and is thereby involved in the maintenance of genetic accuracy.

In addition to its role in chromatin remodeling and gene expression, CHMP1B is also a potential drug target and biomarker. Several studies have identified potential small molecules that can interact with CHMP1B and enhance its activity. These small molecules have been shown to have a positive effect on gene expression and can be used to inhibit the activity of CHMP1B.

One of the most promising small molecules that has been identified as a potential drug target for CHMP1B is the drugletrepant, which is a compound that is derived from the extract of the tropical colubri butterfly. The active ingredient in the extract is known as colubriin, which is a natural product that has been shown to have a positive effect on gene expression.

Colubriin is a purine nucleosome-remodeling protein that is similar to CHMP1B in its structure and function. It is expressed in various tissues and is involved in the regulation of gene expression, DNA replication, and chromatin remodeling. Colubriin has been shown to have a positive effect on gene expression and can be used to enhance the activity of CHMP1B.

Another potential drug target for CHMP1B is the protein known as p16, which is a key regulator of the RTC. p16 is a 21-kDa protein that is composed of 21 amino acid residues and is localized to the nuclear envelope. It is involved in the regulation of chromatin remodeling and has been shown to play a crucial role in the development and maintenance of chromatin.

p16 is a potential drug target for CHMP1B because it is a negative regulator of the RTC, which is similar to CHMP1B in its function. By inhibiting the activity of p16, it is possible to enhance the activity of CHMP1B and improve its ability to regulate gene expression.

In conclusion, CHMP1B is a key regulator of chromatin remodeling and has been shown to play a crucial role in the development and maintenance of chromatin. It is also a potential drug target and biomarker, and several small molecules have been identified that can interact with CHMP1B and enhance its activity. Further research is needed to fully understand the role of CHMP1B in chromatin remodeling and to develop effective drugs that can target its activity.

Protein Name: Charged Multivesicular Body Protein 1B

Functions: Probable peripherally associated component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Involved in cytokinesis. Involved in recruiting VPS4A and/or VPS4B and SPAST to the midbody of dividing cells. Involved in HIV-1 p6- and p9-dependent virus release

The "CHMP1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHMP1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets